GET THE APP

CELL-BASED THERAPY FOR MS PATIENTS DURING COVID-19 PANDEMIC PRACTICAL RECOMMENDATIONS FOR CLINICAL TRIALS | Abstract
Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 20 3868 9735

Abstract

CELL-BASED THERAPY FOR MS PATIENTS DURING COVID-19 PANDEMIC PRACTICAL RECOMMENDATIONS FOR CLINICAL TRIALS

SeyedMassood Nabavi

COVID-19 causing by SARS corona virus type 2 is a pandemic infection since December 2019 and more than 2 million related mortalities reported all over the world. Underlying issues including pulmonary diseases, older age, obesity and high BMI, chronic inflammation, and being under immunosuppression treatment are predisposing factors in COVID-19. Modeling this disease can promote research in order to find practical solutions in this condition.

Published Date: 2021-09-25;